Dabigatran vs. warfarin in relation to the presence of left ventricular hypertrophy in patients with atrial fibrillation— the Randomized Evaluation of Long-term anticoagulation therapY (RE-LY) study

Author:

Verdecchia Paolo1,Reboldi Gianpaolo2,Angeli Fabio3,Mazzotta Giovanni1,Lip Gregory Y H4,Brueckmann Martina56,Kleine Eva5,Wallentin Lars7,Ezekowitz Michael D89,Yusuf Salim10,Connolly Stuart J10,Di Pasquale Giuseppe11

Affiliation:

1. Department of Medicine, Hospital of Assisi, Assisi, Italy

2. Department of Medicine, University of Perugia, Perugia, Italy

3. Department of Cardiology and Cardiovascular Pathophysiology, Hospital S.M. della Misericordia, Perugia, Italy

4. University of Birmingham Institute of Cardiovascular Sciences, City Hospital, Birmingham, UK

5. Boehringer Ingelheim GmbH & Co, Ingelheim am Rhein, Germany

6. Faculty of Medicine Mannheim, University of Heidelberg, Mannheim, Germany

7. Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden

8. Sidney Kimmel Medical College at Jefferson University, Philadelphia, PA, USA

9. Medical College and Lankenau Medical Center, Wynnewood, PA, USA

10. McMaster University, Hamilton, Ontario, Canada

11. Department of Cardiology, Maggiore Hospital, Bologna, Italy

Publisher

Oxford University Press (OUP)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3